Lidya Genomics

Lidya Genomics, established in 2021, aims to bridge the gap between advanced genomic technologies and their practical use across various fields. The company provides powerful, user-friendly software tools and platforms for researchers and healthcare professionals, utilizing state-of-the-art algorithms, machine learning techniques, and data visualization capabilities. These solutions deliver accurate, actionable, and interpretable results, supporting the exploration of the genetic basis of diseases and the assessment of targeted therapies. Based in Turkey and operating in the Life Sciences industry, Lidya Genomics is dedicated to promoting collaboration, speeding up research, and supporting the development of personalized treatments for a broad spectrum of diseases. Although there is no public information available about their last investment, the company continues to drive scientific discovery and strive for widespread access to advanced genomic analysis tools.